Race Oncology (ASX:RAC) Shares Up 4.5%

Race Oncology Ltd (ASX:RAC)’s stock price shot up 4.5% on Monday . The company traded as high as A$0.12 ($0.08) and last traded at A$0.12 ($0.08), 1,100 shares traded hands during mid-day trading. The stock had previously closed at A$0.11 ($0.08).

The stock’s 50 day moving average is A$0.07 and its two-hundred day moving average is A$0.07. The company has a market capitalization of $9.46 million and a PE ratio of -2.50.

In other Race Oncology news, insider William Garner 5,000,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th.



Race Oncology Company Profile (ASX:RAC)

Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It develops Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016.

Recommended Story: Why Net Income is Important to Investors

Receive News & Ratings for Race Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Race Oncology and related companies with MarketBeat.com's FREE daily email newsletter.